We need better post-approval monitoring and reporting to assess the efficiency of new cancer therapies in the real world beyond clinical trials. [Image: see text]
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11014898 | PMC |
| http://dx.doi.org/10.1038/s44319-024-00079-9 | DOI Listing |
Publication Analysis
Top Keywords
clinical trials
8
trials tribulations
4
tribulations better
4
better post-approval
4
post-approval monitoring
4
monitoring reporting
4
reporting assess
4
assess efficiency
4
efficiency cancer
4
cancer therapies
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!